Conatus Pharmaceuticals Inc. (CNAT)

[Inoviorulez]

It is one of the best long-term biotechs out there. That is because if Emricasan pans out greatly in liver disease, and the new inidcations it will be a multi-billion dollar drug. A single drug that can treat so many different big markets is worth a large amount. big pharma will do whatever it can to get its hands on it. The new money will now expand Emricasan into heart disease, lung fibrosis, which are also multibillion dollar markets like NASH.